Skip to main content
TBI
NYSE Trade & Services

TrueBlue Responds to Activist EHS Investments Amidst Proxy Contest

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Negative
Importance info
8
Price
$4.14
Mkt Cap
$124.459M
52W Low
$3.44
52W High
$7.78
52W Position info
20% above low
Off High info
47% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TBI sits 20% above its 52-week low of $3.44.

Summary

TrueBlue, Inc. issued a press release responding to EHS Investments' "misleading statements" as the activist investor continues its proxy contest, highlighting recent board refreshment and denying refusal to engage.


Key Events · Corporate Governance and Compliance · TBI

  • Proxy Contest Confirmed

    TrueBlue acknowledges that EHS Investments is pressing forward with a proxy contest for the 2026 Annual Meeting of Shareholders.

  • Public Dispute with Activist

    The company issued a press release directly refuting "misleading statements" from EHS Investments, indicating a public and contentious battle over corporate governance.

  • Board Refreshment Highlighted

    TrueBlue emphasized recent board appointments of William Greenblatt and William Seward, and the upcoming departure of two existing directors, as evidence of its commitment to board evolution.

  • Financial Performance Defense

    The company reiterated its Q4 2025 organic revenue growth and plans for profitability improvement, despite recent reports of net losses and asset impairment for fiscal 2025.


Analysis · TBI · Trade & Services

This filing confirms an ongoing and public proxy contest between TrueBlue and activist investor EHS Investments. The company is defending its recent board refreshment actions and financial performance, while accusing EHS of issuing press releases prematurely during engagement attempts. The dispute signals potential instability and distraction for management, especially following the company's recent report of a significant net loss and asset impairment for fiscal 2025. Investors should monitor further developments in this proxy battle, as it could lead to significant changes in the company's board composition and strategic direction.

At the time of this filing, TBI was trading at $4.14 on NYSE in the Trade & Services sector, with a market capitalization of approximately $124.5M. The 52-week trading range was $3.44 to $7.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TBI - Latest Insights

TBI
Jun 05, 2026, 10:51 AM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $6.72
Real-time Price: $7.95 info
Change: +$1.23 (+18%) info
Market Cap: $235.024M info
TBI
May 27, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $5.86
Real-time Price: $7.95 info
Change: +$2.09 (+36%) info
Market Cap: $235.024M info
TBI
May 14, 2026, 5:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.64
Real-time Price: $7.95 info
Change: +$2.31 (+41%) info
Market Cap: $235.024M info
TBI
May 12, 2026, 7:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $5.90
Real-time Price: $7.95 info
Change: +$2.05 (+35%) info
Market Cap: $235.024M info
TBI
May 05, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.11
Real-time Price: $7.95 info
Change: +$1.84 (+30%) info
Market Cap: $235.024M info